Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus multilocularis | NADPH cytochrome P450 reductase | 0.0085 | 0.2162 | 0.4948 |
Trypanosoma cruzi | cytochrome P450 reductase, putative | 0.0085 | 0.2162 | 0.5 |
Echinococcus multilocularis | NADPH dependent diflavin oxidoreductase 1 | 0.0085 | 0.2162 | 0.4948 |
Brugia malayi | Pyridoxal-dependent decarboxylase, pyridoxal binding domain containing protein | 0.0129 | 0.4371 | 0.4062 |
Loa Loa (eye worm) | MH2 domain-containing protein | 0.0241 | 1 | 1 |
Plasmodium falciparum | S-adenosylmethionine decarboxylase/ornithine decarboxylase | 0.0129 | 0.4371 | 1 |
Trichomonas vaginalis | ornithine decarboxylase, putative | 0.0129 | 0.4371 | 1 |
Echinococcus granulosus | NADPH cytochrome P450 reductase | 0.0085 | 0.2162 | 0.4948 |
Chlamydia trachomatis | sulfite reductase | 0.0053 | 0.0521 | 0.5 |
Trichomonas vaginalis | pyridoxal-dependent decarboxylase, putative | 0.0129 | 0.4371 | 1 |
Brugia malayi | flavodoxin family protein | 0.0085 | 0.2162 | 0.1732 |
Echinococcus multilocularis | arachidonate 5 lipoxygenase | 0.0118 | 0.3838 | 1 |
Plasmodium vivax | S-adenosylmethionine decarboxylase-ornithine decarboxylase, putative | 0.0129 | 0.4371 | 1 |
Toxoplasma gondii | diaminopimelate decarboxylase | 0.0129 | 0.4371 | 1 |
Trichomonas vaginalis | sulfite reductase, putative | 0.0085 | 0.2162 | 0.4716 |
Trichomonas vaginalis | conserved hypothetical protein | 0.005 | 0.0378 | 0.0446 |
Trichomonas vaginalis | diaminopimelate decarboxylase, putative | 0.0129 | 0.4371 | 1 |
Leishmania major | NADPH-cytochrome p450 reductase-like protein | 0.0085 | 0.2162 | 0.181 |
Trypanosoma brucei | ornithine decarboxylase | 0.0129 | 0.4371 | 1 |
Mycobacterium leprae | PROBABLE DIAMINOPIMELATE DECARBOXYLASE LYSA (DAP DECARBOXYLASE) | 0.005 | 0.0378 | 0.5 |
Trichomonas vaginalis | diaminopimelate decarboxylase, putative | 0.0129 | 0.4371 | 1 |
Schistosoma mansoni | 5-methyl tetrahydrofolate-homocysteine methyltransferase reductase | 0.0053 | 0.0521 | 0.1356 |
Echinococcus granulosus | NADPH dependent diflavin oxidoreductase 1 | 0.0085 | 0.2162 | 0.4948 |
Mycobacterium tuberculosis | Diaminopimelate decarboxylase LysA (DAP decarboxylase) | 0.0129 | 0.4371 | 0.5 |
Brugia malayi | FAD binding domain containing protein | 0.0085 | 0.2162 | 0.1732 |
Schistosoma mansoni | cytochrome P450 reductase | 0.0085 | 0.2162 | 0.5634 |
Trichomonas vaginalis | NADPH fad oxidoreductase, putative | 0.0076 | 0.1674 | 0.3548 |
Loa Loa (eye worm) | transcription factor SMAD2 | 0.0241 | 1 | 1 |
Schistosoma mansoni | lipoxygenase | 0.0118 | 0.3838 | 1 |
Mycobacterium ulcerans | diaminopimelate decarboxylase LysA | 0.0129 | 0.4371 | 1 |
Schistosoma mansoni | lipoxygenase | 0.0083 | 0.2043 | 0.5321 |
Plasmodium vivax | NADPH-cytochrome p450 reductase, putative | 0.0085 | 0.2162 | 0.181 |
Giardia lamblia | Ornithine decarboxylase | 0.0129 | 0.4371 | 1 |
Leishmania major | p450 reductase, putative | 0.0085 | 0.2162 | 0.181 |
Loa Loa (eye worm) | FAD binding domain-containing protein | 0.0085 | 0.2162 | 0.1732 |
Trypanosoma cruzi | NADPH-dependent FMN/FAD containing oxidoreductase, putative | 0.0085 | 0.2162 | 0.5 |
Loa Loa (eye worm) | pyridoxal-dependent decarboxylase | 0.0129 | 0.4371 | 0.4062 |
Loa Loa (eye worm) | hypothetical protein | 0.0085 | 0.2162 | 0.1732 |
Echinococcus granulosus | arachidonate 5 lipoxygenase | 0.0118 | 0.3838 | 1 |
Entamoeba histolytica | ornithine decarboxylase, putative | 0.0129 | 0.4371 | 0.5 |
Schistosoma mansoni | NADPH flavin oxidoreductase | 0.0043 | 0.0033 | 0.0085 |
Trypanosoma cruzi | cytochrome P450 reductase, putative | 0.0085 | 0.2162 | 0.5 |
Onchocerca volvulus | 0.0129 | 0.4371 | 0.5 | |
Leishmania major | ornithine decarboxylase, putative | 0.0129 | 0.4371 | 1 |
Trichomonas vaginalis | ornithine decarboxylase, putative | 0.0129 | 0.4371 | 1 |
Trypanosoma cruzi | p450 reductase, putative | 0.0085 | 0.2162 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (functional) | = 32.6 ug ml-1 | Cytotoxicity against human MCF7 cells after 96 hrs by MTT assay | ChEMBL. | 22204901 |
IC50 (functional) | = 35.6 ug ml-1 | Cytotoxicity against human HepG2 cells after 96 hrs by MTT assay | ChEMBL. | 22204901 |
IC50 (ADMET) | = 35.8 ug ml-1 | Cytotoxicity against human WI38 cells after 96 hrs by MTT assay | ChEMBL. | 22204901 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.